ALIGOS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 23 Jan 2026)
What this means for you
Registered since 05 Nov 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88048683
- Registration number
- 5904485
- Mark type
- Stylized text
- Filed
- 23 Jul 2018
- Published for opposition
- 25 Dec 2018
- Registered
- 05 Nov 2019
- Attorney of record
- Rosaleen H. Chou
Goods and services
- Class 042 — Scientific and technological services: Product research and development; scientific research and development in the field of pharmaceutical drugs; pharmaceutical drug research and development
Owner
- Aligos Therapeutics, Inc., South San Francisco, CA, US
- Aligos Therapeutics, Inc., South San Francisco, CA, US
- Aligos Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 23 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Jan 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Oct 2025 — TEAS SECTION 8 & 15 RECEIVED
- 05 Nov 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Nov 2019 — REGISTERED-PRINCIPAL REGISTER
- 04 Oct 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Oct 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Sept 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Aug 2019 — USE AMENDMENT FILED
- 14 Sept 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Aug 2019 — TEAS STATEMENT OF USE RECEIVED
- 19 Feb 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Dec 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Dec 2018 — PUBLISHED FOR OPPOSITION